TrialHaematologica2022

A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study.

Uday R Popat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.